A Review of Extended Spectrum β-Lactamase (ESBL) Producing Klebsiella pneumoniae and Multidrug Resistant (MDR) on Companion Animals

Klebsiella pneumonia has become most successful and modern pathogen by producing Extended Spectrum β-Lactamase (ESBL). This pathogen can survive as a commensal and can be transferred to humans and animal. This gram-negative bacterium is major source of pneumonia and hospital-based infections. Epidemiological investigation of ESBL produced by Klebsiella pneumonia is main source of epidemic strains. This ESBL producing pathogen is a major clinical threat, involve high rate of morbidity and mortality. Development of novel antimicrobials are required for successful treatment along with infectious disease control. This mini review provides general overview about recent research carried out related to ESBL producing Klebsiella pneumonia. It also briefly shed a light on epidemiological investigation, transmission and possible treatment along with multidrug resistance.